Trial intelligence / Profile preview

N-acetylcysteine for severe alcoholic hepatitis

ChiCTR2000030583Phase 4Recruiting

Sponsor
The Fifth Medical Center of the PLA General Hospital
Start
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of acetylcysteine in alcoholic hepatitis (AH) (2 arms), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoints: survival rate, liver function and 1 more. Started Jun 2016; status: recruiting.

02

Drugs

acetylcysteine
03

Conditions

alcoholic hepatitis (AH)

Beyond the preview

Go deeper on ChiCTR2000030583.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000030583.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call